|
|
tetanus peptide melanoma vaccine A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Abbreviation: | | Tet p | | |
|
|